Condition
Epigenomics clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Epigenomics clinical trials that are recruiting, at sites in 2 countries (most in France (1), Denmark (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
mSEPT9 biomarker to predict liver cancer in people with cirrhosis
This study tests whether a blood biomarker called mSEPT9 can predict the development of hepatocellular carcinoma in people with cirrhosis.
-
Exploring exercise and molecular factors in cancer-related muscle loss
This study tests whether exercise can help people with non-small cell lung cancer who are losing muscle mass feel better and improve their quality of life.
Related topics
Quick answers
How many Epigenomics clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in France (1 trial), Denmark (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.